Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-21

Clinical Trial Update: The Treatment of Shoulder Pain in Hemiplegic Spastic Patients With Botulinum Toxin A [Phase 4]

View source ↗

Summary

Clinical trial updates the use of Botulinum Toxin A for shoulder pain in hemiplegic spastic patients in a Phase 4 study; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: Faculdade de Ciências Médicas da Santa Casa de São Paulo | Conditions: Shoulder Pain | Phase 4 | Status: COMPLETED